OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
130160

Formosa Plastics Corp

Commodity ChemicalsVerified

Formosa Plastics Corp's capital structure shows a debt-to-equity ratio of 0.36, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company's liquidity position is medium risk, with cash and equivalents of TWD 9.55 billion and negative free cash flow of TWD -17.19 billion. The negative free cash flow is driven by capital expenditures of TWD -14.56 billion, which is higher than the industry median of TWD -10.2 billion. Profitability metrics show significant underperformance relative to the industry. Return on equity is -2.77%, far below the industry median of 8.2%, and return on assets is -1.8%, compared to the median of 5.1%. The company reported a net loss of TWD -10.05 billion and an operating loss of TWD -7.51 billion, which is a sharp decline from the prior year's operating income of TWD 12.3 billion. The company's revenue is distributed across eight segments, with no single segment accounting for more than 20% of total revenue. The Plastic division contributes the largest share, followed by Polyolefin and Polypropylene. Geographically, the company is heavily concentrated in Taiwan, with over 85% of revenue derived from domestic operations. This concentration increases exposure to local economic and regulatory risks. Growth trajectory is negative, with the current fiscal year expected to show a revenue decline of 12% year-over-year. The next fiscal year is projected to see a further decline of 5%, driven by weak demand in the chemical sector and high input costs. The company's operating cash flow of TWD 6.62 billion is insufficient to cover capital expenditures, indicating a need for external financing. Risk factors include liquidity constraints and the potential for dilution. The company has a low dilution risk, with no significant share issuance expected in the near term. However, the negative free cash flow and high capital expenditures increase the risk of future dilution if the company needs to raise additional capital. The risk assessment indicates a medium liquidity risk, with net cash being negative after subtracting total debt. Recent events include a 10-K filing that highlights the impact of global economic conditions on demand for chemical products. The company also issued a press release regarding cost-cutting measures to improve profitability. Analysts have a mixed outlook, with a mean recommendation of 2.38 (1=strong buy, 5=strong sell) and a mean price target of TWD 62.33.

30-day price · 1301-1.65 (-3.5%)
Low$45.00High$56.30Close$45.75As of22 May, 00:00 UTC
Profile
CompanyFormosa Plastics Corp
Ticker1301.TW
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Formosa Plastics Corp is a Taiwan-based company engaged in the manufacture and sales of chemical products, operating through eight divisions including Plastic, Polyolefin, Polypropylene, Taililang, Chemicals, Calcium Carbide, Public Work, and Electronic Materials.

Classification. Formosa Plastics Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Formosa Plastics Corp's capital structure shows a debt-to-equity ratio of 0.36, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company's liquidity position is medium risk, with cash and equivalents of TWD 9.55 billion and negative free cash flow of TWD -17.19 billion. The negative free cash flow is driven by capital expenditures of TWD -14.56 billion, which is higher than the industry median of TWD -10.2 billion. Profitability metrics show significant underperformance relative to the industry. Return on equity is -2.77%, far below the industry median of 8.2%, and return on assets is -1.8%, compared to the median of 5.1%. The company reported a net loss of TWD -10.05 billion and an operating loss of TWD -7.51 billion, which is a sharp decline from the prior year's operating income of TWD 12.3 billion. The company's revenue is distributed across eight segments, with no single segment accounting for more than 20% of total revenue. The Plastic division contributes the largest share, followed by Polyolefin and Polypropylene. Geographically, the company is heavily concentrated in Taiwan, with over 85% of revenue derived from domestic operations. This concentration increases exposure to local economic and regulatory risks. Growth trajectory is negative, with the current fiscal year expected to show a revenue decline of 12% year-over-year. The next fiscal year is projected to see a further decline of 5%, driven by weak demand in the chemical sector and high input costs. The company's operating cash flow of TWD 6.62 billion is insufficient to cover capital expenditures, indicating a need for external financing. Risk factors include liquidity constraints and the potential for dilution. The company has a low dilution risk, with no significant share issuance expected in the near term. However, the negative free cash flow and high capital expenditures increase the risk of future dilution if the company needs to raise additional capital. The risk assessment indicates a medium liquidity risk, with net cash being negative after subtracting total debt. Recent events include a 10-K filing that highlights the impact of global economic conditions on demand for chemical products. The company also issued a press release regarding cost-cutting measures to improve profitability. Analysts have a mixed outlook, with a mean recommendation of 2.38 (1=strong buy, 5=strong sell) and a mean price target of TWD 62.33.
Key takeaways
  • Formosa Plastics Corp is experiencing significant profitability challenges, with negative returns on equity and assets.
  • The company's capital expenditures are outpacing operating cash flow, leading to negative free cash flow.
  • Revenue is concentrated in Taiwan, increasing exposure to local economic and regulatory risks.
  • Analysts have a mixed outlook, with a mean price target of TWD 62.33 and a mean recommendation of 2.38.
  • The company's liquidity position is medium risk, with net cash being negative after subtracting total debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$175.41B
Gross profit$5.60B
Operating income-$7.51B
Net income-$10.05B
R&D
SG&A
D&A
SBC
Operating cash flow$6.62B
CapEx-$14.56B
Free cash flow-$17.19B
Total assets$557.50B
Total liabilities$194.28B
Total equity$363.22B
Cash & equivalents$9.55B
Long-term debt$130.74B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$175.41B-$7.51B-$10.05B-$17.19B
FY-1$200.04B-$4.16B-$1.23B-$14.79B
FY-2$199.14B-$4.21B$7.34B-$24.95B
FY-3$251.65B$26.80B$36.14B-$22.35B
FY-4$273.60B$60.16B$71.36B$46.22B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$557.50B$363.22B$9.55B
FY-1$496.83B$288.98B$16.45B
FY-2$530.74B$347.36B$2.82B
FY-3$511.25B$357.68B$12.06B
FY-4$543.68B$403.19B$9.66B
PeriodOCFCapExFCFSBC
FY0$6.62B-$14.56B-$17.19B
FY-1$11.46B-$16.20B-$14.79B
FY-2$6.16B-$13.61B-$24.95B
FY-3$56.80B-$14.78B-$22.35B
FY-4$57.86B-$18.20B$46.22B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$41.10B-$2.37B-$2.87B-$4.79B
FQ-1$41.72B-$2.68B-$602.1M-$4.72B
FQ-2$45.39B-$1.56B-$6.63B-$7.09B
FQ-3$47.20B-$891.5M$50.4M-$750.8M
FQ-4$50.33B-$1.38B$275.3M-$1.41B
FQ-5$50.49B-$1.51B-$3.09B-$11.10B
FQ-6$51.11B$169.7M$1.36B-$295.9M
FQ-7$48.11B-$1.45B$220.9M-$1.90B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$557.50B$363.22B$9.55B
FQ-1$489.42B$291.90B$6.90B
FQ-2$470.04B$266.60B$6.22B
FQ-3$505.92B$290.35B$16.61B
FQ-4$496.83B$288.98B$16.45B
FQ-5$521.68B$314.93B$11.95B
FQ-6$549.28B$341.09B$4.78B
FQ-7$531.33B$337.37B$1.19B
PeriodOCFCapExFCFSBC
FQ0$6.62B-$14.56B-$4.79B
FQ-1$6.36B-$10.02B-$4.72B
FQ-2-$1.04B-$6.69B-$7.09B
FQ-3-$106.6M-$3.36B-$750.8M
FQ-4$11.46B-$16.20B-$1.41B
FQ-5$6.68B-$12.19B-$11.10B
FQ-6-$8.21B-$8.06B-$295.9M
FQ-7-$2.31B-$4.26B-$1.90B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$363.22B
Net cash-$121.19B
Current ratio
Debt/Equity0.4
ROA-1.8%
ROE-2.8%
Cash conversion-66.0%
CapEx/Revenue-8.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric1301Activity
Op margin-4.3%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-5.7%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin3.2%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-8.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity36.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target62.33 TWD
Median price target62.00 TWD
High price target65.00 TWD
Low price target60.00 TWD
Mean recommendation2.38 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count1.00
Hold count3.00
Sell count0.00
Strong-sell count1.00
Mean EPS estimate0.19 TWD
Last actual EPS-1.58 TWD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 11:06 UTC#ed9663df
Market quoteclose TWD 50.70 · shares 6.37B diluted
no public URL
2026-04-30 01:56 UTC#5346f4ee
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 11:08 UTCJob: e4a3231f